Chromosomal changes during development and progression of prostate adenocarcinomas

British Journal of Cancer

Volumn 84, Issue 2, 2001, Pages 202-208

  Zitzelsberger, H ^a,c   Engert, D ^a   Walch, A ^b   Kulka, U ^a   Aubele, M ^b   Hofler H ^a,b   Bauchinger, M ^a   Werner, M ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Comparative genomic hybridization; Prostate carcinoma; Prostatic intraepitherial neoplasia; Tumour progression

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CHROMOSOME 13Q; CHROMOSOME 16; CHROMOSOME 6Q; CHROMOSOME 7; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME 9Q; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CHROMOSOME NUMBER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM;

ADENOCARCINOMA; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; DNA, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS;

EID: 0035147372     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1533     Document Type: Article

References (41)

1. Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: Analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias
2. Comparative FISH analysis of numerical chromosome 7 abnormalities in 5-micron and 15-micron paraffin-embedded tissue sections from prostatic carcinoma
3. Accumulation of chromosomal imbalances during the development and progression of ductal breast cancer
4. Extensive ductal carcinoma in situ with small loci of invasive ductal carcinoma: Evidence of genetic resemblance by CGH
5. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model
6. Review of allelic loss and gain in prostate cancer
7. Prostatic intraepithelial neoplasia and early invasion in prostate cancer
8. Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH)
9. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping
10. Allelic loss detected on chromosomes 8, 10, and 17 by fluorescence in situ hybridization using single-copy P1 probes on isolated nuclei from paraffin-embedded prostate tumors
11. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization
12. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging
13. Allelotype analysis of esophageal adenocarcinomas: Evidence for the involvement of sequences on the long arm of chromosome 4
14. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix
15. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors
16. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer
17. Detection of c-myc oncogene amplification and chromosomal anomalies in metastati prostatic carcinoma by fluorescence in situ hybridization
18. Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal carcinomas with sarcomatoid transformation
19. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization
20. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumours
21. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumours
22. Whole genome amplification and molecular genetic analysis of DNA from paraffin-embedded prostate adenocarcinoma tumor tissue
23. Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization
24. Comparative genomic hybridization
25. Precise microdissection of human prostate cancers reveals genotypic heterogeneity
26. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer
27. Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization
28. Genetic alterations in hormone-refractory recurrent prostate carcinomas
29. Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q, and 17p
30. Deletion mapping of chromosome 4q in hepatocellular carcinoma
31. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization
32. Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens
33. Genetic pattern of prostate cancer progression
34. Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer
35. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer
36. Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization
37. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization
38. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasiadysplasia-carcinoma sequence
39. Recurrent chromosomal imbalances detected in biopsy materialfrom oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization
40. Genetic heterogeneity in a prostatic carcinoma and associated prostatic intraepithelial neoplasia as demonstrated by combined use of laser-microdissection, degenerate oligonucleotide primed PCR and comparative genomic hybridization